| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |